Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Briciclib · ON 013105, ON-014185

Small molecule · Inhibitor of cyclin D1 (CCND1) · developed by Traws Pharma

Phase 1 Most advanced trial (none active)
TRAW Developer
2 Registered trials

What is Briciclib?

Briciclib is a phosphate ester prodrug of ON 013100, a benzyl styryl sulfone analog that is converted to its active form on hydrolysis. The active compound blocks cyclin D mRNA translation and reduces cyclin D protein, which may induce cell cycle arrest and apoptosis in cancer cells that overexpress cyclin D. It is studied in lymphoma, acute lymphocytic leukemia, and advanced solid tumors.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
ON 013105, ON-014185
Drug type
Small molecule
Targets
cyclin D1 (CCND1)
Mechanism
Inhibitor of cyclin D1 (CCND1)
Pathways
cell cycle regulation, cyclin D mRNA translation, apoptosis
Therapy area
Oncology
Developer
Traws Pharma, Inc. (TRAW)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1
UNII
WG93X96336

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02168725 Phase 1 Neoplasms Terminated TRAW
NCT01049113 Phase 1 Lymphoma Terminated TRAW

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Acute Lymphocytic LeukemiaAdvanced Solid TumorLymphomaNeoplasms

More from Traws Pharma

Sources

Updated Nov 1, 2026. Something wrong or missing? Report it on the TRAW page.

Follow TRAW, the company behind Briciclib

See TRAW's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

TRAW catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.